Summary:
The purpose of this research study is to learn about the efficacy and safety of a new study medication in mildly active SLE patients.
Qualified Participants Must:
• Be at least 18 years of age
•
Be on a stable dose of SLE medications for at least the last 4-6 weeks
•
Not have any history of cancer